CompletedPhase 2NCT02680379

Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Université de Sherbrooke
Principal Investigator
François Corbin, MD/PhD
Fragile X Clinic, Centre de recherche du CHUS
Intervention
Minocycline, then Minocycline/Lovastatin(drug)
Enrollment
22 enrolled
Eligibility
8-45 years · All sexes
Timeline
20162017

Study locations (1)

Collaborators

FRAXA Research Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02680379 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials